Pharmacovigilance Risk Assessment Committee (PRAC) published new recommendations subsequent to the Esmya referral
5/18/2018
Business related Regulatory Marketing authorization application Women's Healthcare PRODUCT - ESMYA API - ULIPRISTAL ACETATE